-transparent.png){kind=logo}
Infection of BALB/c mice with mouse hepatitis virus, strain JHM (MHV-JHM), at any of several intervals relative to ovalbumin (OVA) administration resulted in elevated OVA-specific IgG 2 a titers. Since gamma interferon (IFN) has been implicated as an up-regulator of IgG 2 a production, attempts were made to determine whether levels of this cytokine were modified in sera of infected mice. Serum IFN-gamma was not detected, but treatment of MHV-JHM-infected mice with monoclonal anti-IFN-gamma antibody resulted in high mortality with decreased survival times, enhanced virus titers in liver and spleen, and more severe virus-associated pathology, compared to mock-treated, infected mice. Immunotherapy with recombinant IFN-gamma ameliorated disease as reflected by mortality rates and virus titers in target organs.
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
October 1993,
Journal of neuroimmunology,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
January 2008,
Journal of virology,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
January 1995,
Advances in experimental medicine and biology,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
December 1981,
Infection and immunity,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
March 1985,
The Journal of general virology,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
May 1988,
The Journal of general virology,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
December 1996,
Virus research,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
January 1981,
Advances in experimental medicine and biology,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
January 1985,
Medical microbiology and immunology,
A L Smith, and
S W Barthold, and
M S de Souza, and
K Bottomly
January 1990,
Advances in experimental medicine and biology,
